Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1186194-15-9

Post Buying Request

1186194-15-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1186194-15-9 Usage

General Description

Methyl 3-amino-2,5-difluorobenzoate is a chemical compound with the molecular formula C9H8F2NO2. It is a derivative of benzoic acid and contains a methyl group, an amino group, and two fluorine atoms substituted on the benzene ring. methyl 3-amino-2,5-difluorobenzoate is often used in pharmaceutical and chemical processes, particularly in the synthesis of various organic compounds. It may also have potential applications in the development of new drugs and agrochemicals. The presence of the amino and fluorine groups in this compound gives it unique reactivity and properties, making it valuable in a variety of chemical reactions and processes.

Check Digit Verification of cas no

The CAS Registry Mumber 1186194-15-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,6,1,9 and 4 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1186194-15:
(9*1)+(8*1)+(7*8)+(6*6)+(5*1)+(4*9)+(3*4)+(2*1)+(1*5)=169
169 % 10 = 9
So 1186194-15-9 is a valid CAS Registry Number.

1186194-15-9Upstream product

1186194-15-9Downstream Products

1186194-15-9Relevant articles and documents

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

-

Page/Page column 41, (2011/04/14)

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I) and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment

N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER

-

Page/Page column 48, (2009/10/22)

Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1186194-15-9